PATENT CLAIM ANALYSIS

Application Number: 15759203
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "009400"]

Abstract:
This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.

Claim (Index 16):
The composition of  claim 13 , wherein the at least one HGF agent comprises an agonist of HGF.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12685510', '13549770', '14071559', '10133234', '14821567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7547436402677242
- 35 USC 102 Novelty (BERT): 0.537385561670471
- Combined Prediction Score: 0.7330078324079989
- Mean Citation Score: 295.559032
- Max Citation Score: 328.05212
- Similarity Product: 176.04680488995552

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test